It’s illegal to consider past complaints against other employers during hiring. Doing so could expose your business to exactly the risk you're trying to avoidIf a job candidate has sued a previous ...

But with regards to PDS Biotech and our VERSATILE 002 trial, as you know, one of the key characteristics ... I think one of the key things within oncology today with the current cytotoxic drugs ...

Rwanda is ambitiously positioning herself to become a biotechnology hub on the African continent through pharmaceutical ...

The easiest way to do that is to delay your claim past full retirement age, which is 67 if you were born in 1960 or later. For each year you hold off, up until age 70, your benefits increase 8%.

and I’m going to do my best to make you guys happy. See you soon, bye,” she concluded. It’s unknown if Perry has responded yet. In the meantime, here are five facts about the actress that ...

A safety squeeze! You don’t see that very often. Nicely done, too. The Phillies can do no wrong at this particular point in time. You’ve got Taijuan Walker out here looking like the second coming of ...

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.48 per share a year ago.

Understanding how to interpret a company’s earnings report can give you an advantage as an individual investor and will help you to determine if Vir Biotechnology, Inc.’s (VIR) stock is worth adding ...

Creative agency VML and biotech companies Lab-Grown Leather Ltd. and The Organoid ... But how exactly are they going to lay their hands on T rex DNA isn't clear. Experts do not think they can do it.

A new wave of longevity-focused innovation is quietly gaining ground, led by Latvian businessman and investor James Richman, who has reportedly begun funding efforts and developing technology to slow, ...

(Photo provided by Northwest Side Community Development Corp.) It’s Friday in Milwaukee, and here are some things we think you should know about. If you would like your event to be considered for this ...

Webb also suggests looking at smaller players in biotech ... It's also battery life. You know, you can't have a robot meant to do different things and then sort of power off.